Bilateral acute iris transillumination following systemic administration of antibiotics

Eye
Paris TranosNikolaos Markomichelakis

Abstract

To describe the demographic characteristics, clinical features, and potential prognostic factors of bilateral acute iris transillumination (BAIT) following oral antibiotic uptake. A retrospective study of 16 consecutive patients who developed BAIT following treatment with systemic antibiotics. Detailed past medical and ocular history was obtained, presenting signs and symptoms were documented and demographic characteristics were analyzed. All patients underwent a complete ocular examination and laboratory investigation. The course of best corrected visual acuity (BCVA), anterior chamber activity, and intraocular pressure (IOP) during the follow-up period were recorded and possible correlations with potential prognosticators were investigated. Fourteen females and two males were included in the present study. The mean age (SD) of the patients was 43 (14) years. All individuals presented conjunctival injection and photophobia and developed bilateral transillumination defects, fixed mid-dilated pupils and pigment dispersion in the anterior chamber. Systemic antibiotics were previously prescribed in all cases (13 patients with moxifloxacin and three patients with clarithromycin) and the mean (SD) interval between onset of symptoms ...Continue Reading

References

Sep 1, 1988·Ophthalmology·A M BrooksW E Gillies
May 3, 2002·Ophthalmology·Nikos N MarkomichelakisGeorge Theodossiadis
Aug 1, 2002·Archives of Ophthalmology·Eric B SuhlerRon Neumann
Oct 6, 2005·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Ilknur Tugal-Tutkun, Meri Urgancioglu
Nov 3, 2005·Current Opinion in Ophthalmology·Quresh Mohamed, Ehud Zamir
Aug 30, 2008·Journal of Cataract and Refractive Surgery·Stephen S LaneShaleen Belani
Mar 13, 2009·Clinical & Experimental Ophthalmology·Nuwan Niyadurupola, David C Broadway
Sep 17, 2009·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·M KerntA Kampik
Feb 18, 2011·Ophthalmic Research·Masamichi FukudaHiroshi Sasaki
Oct 11, 2011·Cutaneous and Ocular Toxicology·David M HinkleFrederick W Fraunfelder
Oct 12, 2011·Archives of Ophthalmology·Ilknur Tugal-TutkunPhilippe Kestelyn
Oct 10, 2012·Archives of Ophthalmology·Nicholas J Butler, Eric B Suhler
Mar 22, 2013·Journal of Ophthalmic Inflammation and Infection·Robert M KnapeJanet L Davis
Jun 15, 2013·Cutaneous and Ocular Toxicology·Paris TranosIlias Georgalas
Aug 7, 2013·Clinics·Heloisa Moraes do NascimentoRubens Belfort
May 7, 2015·Arquivos brasileiros de oftalmologia·Saban Gonul, Banu Bozkurt
Nov 19, 2015·International Ophthalmology·Andrew Xingyu ZhouBalamurali Krishna Ambati

❮ Previous
Next ❯

Citations

Sep 26, 2020·Ocular Immunology and Inflammation·Alicia ZubicoaEsther Compains Silva
Jul 2, 2020·BMJ Case Reports·Benjamin Tsun Kiu HuiXiaoxuan Liu
Jan 14, 2021·Survey of Ophthalmology·Maram E A Abdalla Elsayed, Igor Kozak
Jan 15, 2021·Survey of Ophthalmology·Andres Bustamante-AriasAlejandro Rodriguez-Garcia

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

SPSS
Excel

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.